Skip to main content

ACTION ALERT: In a shocking move, the FDA has just approved a NEW generic form of the deadly abortion pill. Urge the FDA to pull the abortion pill from the market. Click here to contact the FDA Commissioner now.

Live Action LogoLive Action

Press Release

·

FDA Recklessly Approves New Generic Abortion Pill

For Immediate Release
October 2,  2025                                                          
Noah Brandt
VP, Communications
media@liveaction.org

FDA Recklessly Approves New Generic Abortion Pill

Live Action founder Lila Rose calls for immediate reversal

Washington, D.C. – Today, Live Action, one of the nation’s leading human rights organizations, reacts to the FDA’s approval of a new version of Mifepristone, the first pill used during a chemical abortion. 

During a chemical abortion, a pregnant mother takes Mifepristone to starve the preborn child in the womb, then takes misoprostol to induce labor and expel the baby. 

Lila Rose, Founder and President of Live Action, issued the following statement:  

“The FDA has made a reckless and harmful mistake. The approval of this new generic version of the abortion pill comes less than one month after Health and Human Services Secretary Robert F Kennedy confirmed that the FDA would conduct a new review of abortion drugs. This dangerous policy is in violation of what Secretary Kennedy has said publicly regarding his concern for the safety of mothers who take the abortion pill. Mifepristone was developed solely to kill babies and in that process they often harm mothers. 

Chemical abortions now account for almost two-thirds of all U.S. abortions, killing 7.5 million preborn children since its approval by the FDA in 2000. 

A recent report, released by the Ethics and Public Policy Center, analyzed insurance claims data from 2017 to 2023 for almost one million chemical abortions and found that 1 in 10 women experienced serious adverse events, such as sepsis, infection, and hemorrhaging. This is at a rate 22% higher than reported by the FDA, 

The FDA is not focused on American healthcare and blatantly disregarding the safety of women and children. FDA Commissioner Marty Makary and HHS Secretary Kennedy Jr. must reverse this decision immediately, for the safety of our nation’s women and children.” 

Under the FDA’s current policy, a chemical abortion requires only one telehealth visit with any healthcare provider (not a physician) and the drugs received from a mail-order pharmacy. This lack of protocols has led to lawsuits such as the recent one in Texas. A woman is suing both her partner and the company that provided him abortion pills by mail, after she unknowingly ingested them and lost her preborn baby, Joy. 

About Lila Rose and Live Action
Lila Rose founded and serves as president of Live Action. Live Action is a 501(c)3 human rights non-profit and the digital leader of the global pro-life movement. Live Action exists today to shift public opinion against abortion and to defend the rights of the most vulnerable. With over 7.5 million social media followers and 2.5 billion lifetime video views, Live Action reaches individuals 43 million times per month– saving lives and transforming hearts, with 43% of surveyed followers saying Live Action’s content has changed their position against abortion. Through compelling educational media, human interest storytelling, investigative reporting, and community activism, Live Action reveals the humanity of preborn children and exposes the abortion industry’s exploitation of women and families for profit. Lila is also the author of Fighting for Life: Becoming a Force for Change in a Wounded World. Find Lila on Twitter at @lilagracerose, and Instagram at @lilaroseofficial, and Facebook at @lilagracerose. Find out more at http://www.liveaction.org.